Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suven Life Sciences has informed that a Meeting of the Board of Directors of the Company will be held on Tuesday, November 11, 2025 at the Registered Office of the Company situated at SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad–500034, to consider and approve, among other things, and take on record the following matter(s): Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half-year ended September 30, 2025 and related matters. The Trading Window for dealing in the Equity Shares of the company by all Designated Persons and their relatives, have been closed from October 01, 2025 as per PIT Code of the Company and shall remain closed up to the expiry of 48 hours after the declaration of the aforesaid financial results.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: